Skip to main content
A

Ambryon

Ambryon provides US‑manufactured adeno‑associated viral (AAV) vectors and a modular Serotype Testing Flex Kit that let researchers assemble custom serotype panels and assess promoter‑reporter performance for specific tissues or cell lines. The company also offers plasmid, transposon, and precision base‑editing reagents with detailed QC data to support reproducible gene delivery and nucleotide editing in academic and biotech labs.

Rockville, United StatesFounded 2024210+ followers
Updated 3 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Researchers often face challenges obtaining high-quality, reliable viral vectors and genome editing tools, leading to inconsistent results and delays in gene delivery experiments. Limited access to US-made, well-characterized AAV serotypes and precision base editors hampers optimization for new cell types and therapeutic targets.

Solution

Ambryon supplies premium, US‑manufactured adeno‑associated viral (AAV) vectors for both in‑vivo and ex‑vivo gene delivery, ensuring consistent performance across experiments. The company also offers a modular AAV Serotype Testing Flex Kit that lets users assemble custom serotype panels and evaluate promoter–reporter combinations for specific tissues or cell lines. In addition, Ambryon provides a suite of molecular biology tools, including plasmid vectors and transposon systems, as well as precision base‑editing reagents for single‑nucleotide conversions without double‑strand breaks. All products are designed for rapid integration into research workflows, with detailed documentation and quality control data to support reproducible results. By centralizing these core gene‑delivery and editing resources, Ambryon enables laboratories to accelerate vector optimization, reduce experimental variability, and advance therapeutic development.

Target Audience

Primary customers are academic and industry researchers developing gene‑therapy vectors, cellular models, or precision‑editing therapeutics, including molecular biologists, virologists, and biotech R&D teams.

Features

  • US‑made AAV vectors covering multiple serotypes, each batch tested for purity, titer, and functional activity
  • AAV Serotype Testing Flex Kit allowing on‑demand assembly of custom serotype panels with selectable promoter–reporter combos
  • Comprehensive CRISPR and base‑editing reagents (adenine and cytosine editors) for precise, scar‑free nucleotide changes
  • Plasmid and transposon vector collections for versatile transgene delivery and stable genomic integration
  • Detailed product datasheets, QC certificates, and protocol guides to streamline experimental setup
  • Compatibility with standard molecular biology workflows and downstream applications such as protein expression and functional assays
This profile is AI-generated and may contain inaccuracies.